or
forgot password
  • cancer clinical trials in chicago, IL

  • Mitotane With or Without IMC-A12 in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    Recurrent Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Illinois Masonic Medical Center

    Trial Locations
    Illinois Masonic Medical Center
    Swedish Covenant Hospital
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    John H Stroger Jr Hospital of Cook County
    University of Illinois
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1)
    University of Chicago Comer Children's Hospital
    Chicago, Illinois 60637
    Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology and Oncology Associates
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
    University of IL at Chicago
    Chicago, Illinois 60612
    Multiple Myeloma, Plasma Cell Neoplasm
    Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
    Comer Children's Hospital University of Chicago
    Chicago, Illinois 60637
    Juvenile Idiopathic Arthritis
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Hematology and Oncology Associates

    Trial Locations
    Hematology and Oncology Associates
    Northwestern University
    University of Chicago Comprehensive Cancer Center
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Swedish Covenant Hospital

    Trial Locations
    Swedish Covenant Hospital
    Northwestern University
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    John H Stroger Jr Hospital of Cook County
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University

    Trial Locations
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    John H. Stroger, Jr. Hospital of Cook County
    Endometrial Cancer, Fatigue, Neurotoxicity
    Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology and Oncology Associates
    John H. Stroger, Jr. Hospital of Cook County
    Lymphoma
    BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University

    Trial Locations
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University
    Hematology and Oncology Associates
    Saint Joseph Hospital
    Lung Cancer
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    University of Chicago Comprehensive Cancer Center

    Trial Locations
    University of Chicago Comprehensive Cancer Center
    Childrens Memorial Hospital
    University of Illinois
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma
    Northwestern Memorial Hospital
    Chicago, Illinois 60611
    Hepatocellular Carcinoma
    Characterization of Receptors in Non-functioning Pituitary Macroadenomas
    John H Stroger Jr. Hospital of Cook County
    Chicago, Illinois 60612
    Pituitary Tumor
    A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1
    University of Chicago
    Chicago, Illinois 60637
    Neurofibromatosis Type 1
    S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    University of Chicago Cancer Research Center

    Trial Locations
    University of Chicago Cancer Research Center
    Resurrection Medical Center
    Breast Cancer
    Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
    Northwestern University
    Chicago, Illinois 60611
    Liver Cancer, Metastatic Cancer
    Monthly SOM230C for Recurrent or Progressive Meningioma
    Northwestern University
    Chicago, Illinois 60611
    Meningioma
    LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
    Northwestern University
    Chicago, Illinois 60611
    Malignant Glioma
    Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
    University of Chicago Comprehensive Cancer Center
    Chicago, Illinois 60637-1470
    High-grade Salivary Gland Mucoepidermoid Carcinoma, Low-grade Salivary Gland Mucoepidermoid Carcinoma, Recurrent Salivary Gland Cancer, Salivary Gland Acinic Cell Tumor, Salivary Gland Adenocarcinoma, Salivary Gland Adenoid Cystic Carcinoma, Salivary Gland Anaplastic Carcinoma, Salivary Gland Malignant Mixed Cell Type Tumor, Salivary Gland Poorly Differentiated Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer
    A Weight-Loss Program in Helping Obese Black Women Lose Weight
    University of Illinois Cancer Center
    Chicago, Illinois 60612-7243
    Breast Cancer, Obesity, Weight Changes
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    University of Chicago
    Chicago, Illinois 60637
    Prostate Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Mount Sinai Hospital Medical Center

    Trial Locations
    Mount Sinai Hospital Medical Center
    University of Chicago Comprehensive Cancer Center
    John H Stroger Jr Hospital of Cook County
    Resurrection Healthcare
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Rush University Medical Center

    Trial Locations
    Rush University Medical Center
    Northwestern University
    Peripheral T-cell Lymphoma